WEST PHARMACEUTICAL SERVICES INC (WST) › Operating Cash FlowWEST PHARMACEUTICAL SERVICES INC (WST) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2008: $135.00M2009: $137.70M2010: $138.30M2011: $130.70M2012: $187.40M2013: $220.50M2014: $182.90M2015: $212.40M2016: $219.40M2017: $263.30M2018: $288.60M2019: $367.20M2020: $472.50M2021: $584.00M2022: $724.00M2023: $776.50M2024: $653.40M2025: $754.80M$754.80M2008Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$754.80M+15.5%2024$653.40M-15.9%2023$776.50M+7.3%2022$724.00M+24.0%2021$584.00M+23.6%2020$472.50M+28.7%2019$367.20M+27.2%2018$288.60M+9.6%2017$263.30M+20.0%2016$219.40M+3.3%2015$212.40M+16.1%2014$182.90M-17.1%2013$220.50M+17.7%2012$187.40M+43.4%2011$130.70M-5.5%2010$138.30M+0.4%2009$137.70M+2.0%2008$135.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share